Catalyst Wire Dossier Catalyst Wire Dossier

IVRA

melphalan hydrochloride · Apotex Corp
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IVRA, covering 2023-08-18 to 2024-07-22. Get the full timeline:

Most recent: FDA Approved: IVRA — Supplemental Application (Apotex Corp)

See pricing